Lab Information

Jean-Pierre Routy (MD)

Senior Scientist
Centre for Translational Biology
Department of Medicine (McGill)

Research Profile

 Fundamental: 50%
 Clinical: 50%
 Epidemiology: 0%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

HIV • chronic viral infections • CMV • HHV8 • HIV reservoirs • gut

Research Interests

My research focuses on human immunodeficiency virus (HIV) pathogenesis aiming at finding an HIV cure. Improving knowledge in immune tolerance in cancer and immunometabolism will be key to developing strategy to conquer cancers and auto-immune diseases.


Team Members

Name Position

Latest Publications

  1. Sun, L., Isnard, S., Zhu, H., Chen, J., He, Y., Lu, H. & Routy, J.-P. (2026). Immunometabolic reprogramming via GLP-1 receptor agonists in people with HIV: A multidimensional systemic framework. Bioscience trends.
  2. Laymouna, M., Engler, K., Lessard, D., Belin, M., Vicente, S., Chu, D., Yaphe, S., Cox, J., Kronfli, N., Routy, J.-P., Ishak, J., Hamel, A., Klein, M., de Pokomandy, A., Costiniuk, C. T. & Lebouché, B. (2026). Material deprivation and its correlates in treatment-naïve migrants with HIV with rapid access to B/F/TAF at no cost: A sub-study of the ASAP cohort. HIV medicine.
  3. Nodzynski, K., Lessard, D., Chu, D., Kronfli, N., Dufrêne-Boelen, C., Yaphe, S., Klein, M., Routy, J.-P., Hamel, A., Costiniuk, C., de Pokomandy, A., Vicente, S., Moonsamy, K., Popovic, N., Cox, J. & Lebouché, B. (2026). Migration pathways and HIV care Cascade among newly enrolled adult patients in a tertiary clinic in Montréal, Canada. HIV medicine.
  4. Santangelo, M., Bendoumou, M., Dutilleul, A., Khalfi, S., Plant, E., Ngassaki-Yoka, C. D., Pilosio, L., Vanhulle, C., Dias, J., Marray, T., Fattaccioli, A., Verhasselt, B., Lange, U., Dieu, M., Routy, J.-P., Rohr, O., Renard, P., Ancuta, P. & VAN Lint, C. (2026). Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription. Research square.
  5. Moreira Gabriel, E., Moreaux, J., Kaofai, C., Majidi Ivari, K., Schmouth, J.-F., Goulet, J.-P., Dias, J., Wiche Salinas, T. R., Raymond Marchand, L., Khalfi, S., Routy, J.-P., Durand, M., El-Far, M., Tremblay, C. L. & Ancuta, P. (2026). Pharmacological and genetic modulation of IL-32 expression in intestinal epithelial cells does not impact HIV-1 outgrowth in co-cultured CD4+ T-cells. Frontiers in immunology, vol. 17, p. 1769388.
  6. Rong, Y., Lambertucci, F., Yang, Y., Carbonnier, V., Chen, H., Dong, Y., Mingoia, S., Li, S., Motiño, O., Montégut, L., Joseph, A., Ferret, L., Saavedra Díaz, E. G., Isnard, S., Routy, J.-P., Djavaheri-Mergny, M., Castedo, M., Fuerlinger, A., Abdellatif, M., Maiuri, M. C., Martins, I. & Kroemer, G. (2026). Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation. Cell death and differentiation.
  7. Cinque, F., Nudo, M., Saeed, S., Lim, J., Kablawi, D., Mariano, G., Lupu, A., Elgretli, W., Moodie, E. E. M., Price, C., Monteith, K., Cooper, C., Walmsley, S., Kronfli, N., Cox, J., Costiniuk, C., De Pokomandy, A., Routy, J.-P., Klein, M. B., Lebouche, B. & Sebastiani, G. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV. Gastro hep advances, vol. 5, p. 100966.
  8. Santangelo, M., Bendoumou, M., Dutilleul, A., Khalfi, S., Plant, E., Ngassaki-Yoka, C. D., Pilosio, L., Vanhulle, C., Dias, J., Marray, T., Fattaccioli, A., Dieu, M., Routy, J.-P., Rohr, O., Renard, P., Ancuta, P. & VAN Lint, C. (2026). Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription. bioRxiv : the preprint server for biology.
  9. Al-Abdulmalek, A., Isnard, S., Watters, A. A. & Routy, J.-P. (2026). From suspected brain malignancy to Erdheim-Chester disease: the role of PET imaging and bone marrow biopsy in diagnosis. Oxford medical case reports, vol. 2026, p. omag049.
  10. Meissner, E. G., Ramgopal, M., Ruane, P. J., Sanchez, W., Crofoot, G., Routy, J.-P., Brinson, C., DeJesus, E., Martorell, C. T., Tellez, M., Yokomaku, Y., O'Reilly, M., Lupo, S., Schellberg, S., Lezama-Mora, J. I., Chin, B., Aizen, K., D'Antoni, M. L., Huang, H., Mponponsuo, K., Montezuma-Rusca, J. M., Sklar, P., Rhee, M., Hung, C.-C. & ARTISTRY-2 Study Group (2026). Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. The lancet. HIV, vol. 13, p. e538-e547.
More on PubMed 



See also

Card image
Bertrand
Lebouché


See profile
Card image
Cecilia
Costiniuk


See profile
Card image
Marina
Klein


See profile
Card image
Joseph
Cox


See profile
Card image
Alexandra
De Pokomandy


See profile